Ozempic, Wegovy and other GLP-1 drugs to carry vision loss warning after FDA finds rare eye risk
US regulators say the rare eye condition NAION can cause permanent vision loss. All GLP-1 drugs, including Ozempic and Wegovy, will now carry the warning.
We haven't written up this one. Hindustan Times - World News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- FDA orders blindness risk warning on weight loss drugs news.sky.com
- US FDA orders new eye risk warnings for Ozempic, Zepbound investing.com
